Tanja Fens

2 min read

High-dose influenza vaccination remains a cost-effective investment for older adults in the Netherlands

Updated health-economic evidence, drawing on data from more than 85 million individuals, confirms that switching from standard-dose to high-dose influenza vaccination would prevent thousands of hospitalisations each year, at a cost well within...

Read More

2 min read

Health-Ecore and MedEngine Join Forces to Advance Market Access and Real-World Evidence Across Europe

Helsinki, November 4, 2025 — Health-Ecore and MedEngine are joining forces in a new collaboration to enhance market access and real-world evidence...

Read More

1 min read

When AI Meets Systematic Reviews and Shapes the Future of Evidence Synthesis

Imagine a researcher at their desk, surrounded by hundreds of open articles, spreadsheets filled with study data, and the constant ticking of...

Read More

1 min read

Health-Ecore and Pharma & Health Policy Hub Announce Strategic Partnership

Health-Ecore and the Pharma & Health Policy Hub have entered into a strategic partnership to advance research, provide expert advisory services, and...

Read More

Cover photo: Chris Bonis